Thursday, October 1, 2015

Maryland Medical Product Liability Lawyers: FDA Investigating Birth Control Implant

Recently, the Food and Drug Administration held a day-long hearing to address concerns over the popular birth control implant Essure. A panel of experts and members of the pubic discussed the safety and effectiveness of the medical device, marketed as the first and only nonsurgical permanent contraceptive implant currently available. The hearing comes amid a wave of lawsuits filed against Essure’s maker, Bayer HealthCare Pharmaceuticals. Essure consists of two tiny metallic coils inserted into the fallopian tubes that are designed to induce tissue growth and render the woman sterile. The procedure, which has been marketed as a safe alternative to tubal ligation surgery and other forms of birth control, can be completed in a doctor’s office in just minutes. Approximately 750,000 Essure devices have been sold worldwide since the device became available in 2002. Reports of problems began soon after Essure hit the market, but have surged in recent years as more women have opted for th

No comments:

Post a Comment